Literature DB >> 9020452

Hydroxyapatite in revision of total hip replacements with massive acetabular defects: 4- to 10-year clinical results.

H Oonishi1, Y Iwaki, N Kin, S Kushitani, N Murata, S Wakitani, K Imoto.   

Abstract

Hydroxyapatite (HA) granules of 100 to 300 microm, 0.9 to 1.2 mm and 3.0 to 5.0 mm were mixed in a ratio of 10:45:45 and packed into massive bone deficiencies in revision operations for total hip arthroplasty. We did not use additional graft or cup support for deficiencies of the lateral and medial wall. The procedure was carried out in 40 hips between 1986 and 1992. The radiographic spaces seen at the interface between HA and bone immediately after surgery disappeared within three months. Some spaces appeared between HA granules near the bone in the lateral part of two joints, and three sockets migrated in patients with severe segmental and cavitary deficiencies. Direct bonding of HA to bone was observed radiologically without morphological changes, except in the three joints with migration. All patients could walk without pain but the three with definite loosening needed crutches.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020452     DOI: 10.1302/0301-620x.79b1.1290

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  13 in total

1.  Biphasic synthetic bone substitute use in orthopaedic and trauma surgery: clinical, radiological and histological results.

Authors:  C Schwartz; P Liss; B Jacquemaire; P Lecestre; P Frayssinet
Journal:  J Mater Sci Mater Med       Date:  1999-12       Impact factor: 3.896

2.  Shed blood-derived cells from total hip arthroplasty have osteoinductive potential: a pilot study.

Authors:  Tomokazu Yoshida; Masakazu Ishikawa; Yuji Yasunaga; Takuma Yamasaki; Mitsuo Ochi
Journal:  Clin Orthop Relat Res       Date:  2010-06-24       Impact factor: 4.176

3.  Modular acetabular reconstructive cup in acetabular revision total hip arthroplasty at a minimum ten year follow-up.

Authors:  Takashi Sakai; Kenji Ohzono; Takashi Nishii; Masaki Takao; Hidenobu Miki; Nobuo Nakamura; Nobuhiko Sugano
Journal:  Int Orthop       Date:  2013-02-20       Impact factor: 3.075

4.  Phosphocalcium ceramics are efficient in the management of severe acetabular loss in revision hip arthroplasties. A 22 cases long-term follow-up study.

Authors:  C Schwartz; M Vautrin
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-05-11

5.  Bone substitution in revision hip replacement.

Authors:  C Nich; L Sedel
Journal:  Int Orthop       Date:  2006-06-02       Impact factor: 3.075

Review 6.  Recommendations and considerations for the use of biologics in orthopedic surgery.

Authors:  Stefan Zwingenberger; Christophe Nich; Roberto D Valladares; Zhenyu Yao; Maik Stiehler; Stuart B Goodman
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

7.  (Bio)manufactured Solutions for Treatment of Bone Defects with Emphasis on US-FDA Regulatory Science Perspective.

Authors:  Pejman Ghelich; Mehdi Kazemzadeh-Narbat; Alireza Hassani Najafabadi; Mohamadmahdi Samandari; Adnan Memic; Ali Tamayol
Journal:  Adv Nanobiomed Res       Date:  2022-01-05

8.  Impaction grafting of the acetabulum with ceramic bone graft substitute: high survivorship in 43 patients with a mean follow-up period of 4 years.

Authors:  Michael R Whitehouse; Peter J Dacombe; Jason C J Webb; Ashley W Blom
Journal:  Acta Orthop       Date:  2013-08       Impact factor: 3.717

9.  Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: high survivorship in 43 patients with a median follow-up of 7 years: a follow-up report.

Authors:  Michael R Whitehouse; Peter J Dacombe; Jason C J Webb; Ashley W Blom
Journal:  Acta Orthop       Date:  2013-04-17       Impact factor: 3.717

10.  USE OF BIOCERAMICS IN FILLING BONE DEFECTS.

Authors:  Carlos Antõnio Garrido; Tania Clarete Fonseca Vieira Sales Sampaio
Journal:  Rev Bras Ortop       Date:  2015-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.